Mr. Vogel has over 30 years experience in the pharmaceutical and clinical diagnostics industries.
Prior to joining Brighton Biotech he was a consultant providing Regulatory-CMC guidance to the pharmaceutical industry. Previously Mr. Vogel spent 16 years with Bristol-Myers Squibb (B-MS), assuming increasing levels of responsibility, and retiring as Associate Director – Regulatory Science, CMC. He has prepared CMC dossiers (IND, CTA, NDA, MAA, SNDA, and DMF) to secure Regulatory Agency approvals of investigational drugs and major changes to marketed products in various therapeutic areas including: oncology, cardiovascular, anti-infective, anti-viral, and neuroscience.
He holds a BS in Chemistry from Wagner College and an MBA from Pace University.